+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Xerostomia Therapeutics Market - Global Forecast 2025-2030- Product Image
Xerostomia Therapeutics Market - Global Forecast 2025-2030- Product Image
Sale

Xerostomia Therapeutics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889726
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The xerostomia therapeutics market is undergoing accelerated transformation, driven by advances in formulation science, digital integration, and increasing awareness of patient needs. This evolving environment presents actionable opportunities for senior decision-makers aiming to leverage innovation, supply chain agility, and targeted strategies to address unmet demand across clinical, homecare, and institutional settings.

Market Snapshot: Xerostomia Therapeutics Industry Overview

The Xerostomia Therapeutics Market grew from USD 2.35 billion in 2024 to USD 2.46 billion in 2025. It is expected to continue growing at a CAGR of 4.51%, reaching USD 3.07 billion by 2030. Dry mouth, or xerostomia, is increasingly recognized as a considerable challenge affecting patient quality of life and oral health outcomes globally. Factors such as aging populations and chronic disease prevalence are increasing demand, while industry stakeholders in pharmaceuticals, medical devices, and personal care are driving rapid advancements in novel formulations and delivery systems.

Scope & Segmentation

  • Product Types: Gels and sprays, including both mucoadhesive and sustained-release; lozenges, with options such as herbal and xylitol-based; mouthwashes formulated with chlorhexidine, fluoride, or herbal actives; and saliva substitutes built on carboxymethylcellulose and xanthan gum base ingredients.
  • Distribution Channels: Offline touchpoints like clinics, hospital pharmacies, retail pharmacies, and specialty stores; and online avenues such as e-commerce platforms and manufacturer websites.
  • End Users: Homecare settings seeking convenience and discreet packaging; hospitals and clinics prioritizing sterile and precision dosing; specialty dental and oncology centers with unique integration and healing requirements.
  • Geographic Regions: Key markets include the United States, Canada, Brazil, major European economies, select Middle East and African nations, and dynamic Asia-Pacific countries such as China, India, Japan, South Korea, and Australia.
  • Leading Companies: Major contributors include Colgate-Palmolive Company, Haleon plc, Johnson & Johnson, Procter & Gamble Company, Eisai Co., Ltd., Daiichi Sankyo Company, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., and Dr. Reddy’s Laboratories Limited.

Xerostomia Therapeutics Key Takeaways

  • Innovation is rapidly advancing with the emergence of bioadhesive gels, sustained-release sprays, and digital health-enabled oral devices designed for both symptom relief and personalization of care.
  • Artificial intelligence platforms and telehealth integration are facilitating earlier diagnosis and precise, remote therapeutic management for at-risk groups, including patients with complex medication regimes or those undergoing radiation therapy.
  • R&D pipelines are expanding to include natural and botanical actives, such as aloe-infused mouthwashes and herbal lozenges, driven by consumer preference for multifunctional and biocompatible solutions.
  • Strategic company moves—including acquisitions, licensing deals, and collaborations with contract manufacturers—are fostering technology convergence between traditional oral care and biotech innovators.
  • Distribution strategies are evolving to balance immediate access in clinical settings with the convenience and educational value of online platforms and subscription-based models.

Tariff Impact on Xerostomia Therapeutics

Recent tariff increases in the United States have raised costs for specialty raw materials critical to sustained-release gels and salivary substitutes. Manufacturers now prioritize resilience by diversifying suppliers, investing in local production, and forming strategic alliances, enhancing control over logistics and cost management while safeguarding continuity of supply.

Methodology & Data Sources

This analysis uses a blend of secondary research from peer-reviewed literature, clinical registries, patent filings, and regulatory datasets, complemented by primary interviews with clinical experts, procurement leaders, and product developers. Robust triangulation and standardized data verification ensure reliability. Where direct data was unavailable, conservative proxies from related markets have been referenced.

Why This Report Matters

  • Guides strategic decisions by presenting an actionable, segmented view of product, channel, and geographic opportunities within the xerostomia therapeutics sector.
  • Highlights the implications of emerging technologies, market disruptions, and supply chain shifts, equipping stakeholders to proactively manage risk and maximize value.
  • Supports go-to-market strategies by aligning innovation trends with regulatory, clinical, and consumer adoption patterns across both mature and developing economies.

Conclusion

As xerostomia therapeutics evolve, organizations that foster innovation, adapt to regional dynamics, and integrate digital and supply chain strategies will be best positioned. Continuous investment in actionable intelligence drives successful patient outcomes and growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of gene therapy approaches targeting salivary gland regeneration in xerostomia patients
5.2. Development of mucoadhesive nanocarrier systems for sustained salivary secretion enhancement
5.3. Integration of digital salivary flow monitoring devices into personalized xerostomia management plans
5.4. Rise of probiotic and microbiome modulation therapies to restore oral moisture balance in dry mouth
5.5. Launch of long acting oral gels combining salivary stimulants with antimicrobial agents for extended relief
5.6. Adoption of telehealth platforms for remote assessment and management of chronic xerostomia symptoms
5.7. Growth in plant derived bioactive compounds as natural alternatives for dry mouth therapeutic formulations
5.8. Collaboration between pharmaceutical companies and dental technology firms to co develop innovative treatments
5.9. Regulatory approval of first in class small molecule secretagogues targeting muscarinic receptors for dry mouth
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Xerostomia Therapeutics Market, by Product Type
8.1. Introduction
8.2. Gels And Sprays
8.2.1. Gels
8.2.2. Sprays
8.3. Lozenges
8.3.1. Herbal Lozenges
8.3.2. Xylitol Lozenges
8.4. Mouthwash
8.4.1. Chlorhexidine Mouthwash
8.4.2. Fluoride Mouthwash
8.4.3. Herbal Mouthwash
8.5. Saliva Substitutes
8.5.1. Carboxymethylcellulose Based
8.5.2. Xanthan Gum Based
9. Xerostomia Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.2.1. Clinics
9.2.2. Hospital Pharmacies
9.2.3. Retail Pharmacies
9.2.4. Specialty Stores
9.3. Online
9.3.1. E-Commerce Platforms
9.3.2. Manufacturer Websites
10. Xerostomia Therapeutics Market, by End User
10.1. Introduction
10.2. Homecare Settings
10.3. Hospitals And Clinics
10.4. Specialty Clinics
11. Americas Xerostomia Therapeutics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Xerostomia Therapeutics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Xerostomia Therapeutics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Colgate-Palmolive Company
14.3.2. Haleon plc
14.3.3. Johnson & Johnson
14.3.4. Procter & Gamble Company
14.3.5. Eisai Co., Ltd.
14.3.6. Daiichi Sankyo Company, Limited
14.3.7. Teva Pharmaceutical Industries Ltd.
14.3.8. Viatris Inc.
14.3.9. Sun Pharmaceutical Industries Ltd.
14.3.10. Dr. Reddy’s Laboratories Limited
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. XEROSTOMIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. XEROSTOMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. XEROSTOMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. XEROSTOMIA THERAPEUTICS MARKET: RESEARCHAI
FIGURE 22. XEROSTOMIA THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 23. XEROSTOMIA THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 24. XEROSTOMIA THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. XEROSTOMIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HERBAL LOZENGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HERBAL LOZENGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY XYLITOL LOZENGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY XYLITOL LOZENGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CHLORHEXIDINE MOUTHWASH, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CHLORHEXIDINE MOUTHWASH, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY FLUORIDE MOUTHWASH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY FLUORIDE MOUTHWASH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HERBAL MOUTHWASH, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HERBAL MOUTHWASH, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY XANTHAN GUM BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY XANTHAN GUM BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 118. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 119. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 120. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 121. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 122. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 123. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 124. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 125. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 128. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 129. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 130. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 131. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 138. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 139. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 140. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 141. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 230. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 231. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 232. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 233. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 234. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 235. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 248. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 249. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 250. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 251. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 252. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 253. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 282. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 283. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 284. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 285. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 286. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 287. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 288. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 289. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 292. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 293. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 294. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 295. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 302. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 303. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 304. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 305. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 306. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 307. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY GELS AND SPRAYS, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY LOZENGES, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY MOUTHWASH, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVA SUBSTITUTES, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Xerostomia Therapeutics market report include:
  • Colgate-Palmolive Company
  • Haleon plc
  • Johnson & Johnson
  • Procter & Gamble Company
  • Eisai Co., Ltd.
  • Daiichi Sankyo Company, Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Limited

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.46 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.07 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Xerostomia Therapeutics Market Size, Share, Trends and Forecast by Type, Drug Type, Distribution Channel, and Region, 2025-2033 - Product Image

Xerostomia Therapeutics Market Size, Share, Trends and Forecast by Type, Drug Type, Distribution Channel, and Region, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Xerostomia Therapeutics Market Report 2025 - Product Image

Xerostomia Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Global Xerostomia (Dry Mouth Disease) Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Xerostomia (Dry Mouth Disease) Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 117 Pages
  • Global
From
Xerostomia (Dry Mouth) Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Xerostomia (Dry Mouth) Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 120 Pages
  • Global
From
Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report - Product Image

Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From

About the Xerostomia Drug Market

Xerostomia Drug is a type of drug used to treat dry mouth, a condition caused by a decrease in saliva production. Xerostomia is a common symptom of immune disorders, such as Sjogren's Syndrome, HIV/AIDS, and lupus. Xerostomia drugs are designed to increase saliva production and reduce the discomfort associated with dry mouth. These drugs can be taken orally, applied topically, or administered through a nasal spray. Commonly used xerostomia drugs include pilocarpine, cevimeline, and bromhexine. The xerostomia drug market is a rapidly growing segment of the immune disorder drug market. It is driven by the increasing prevalence of immune disorders, as well as the development of new drugs to treat dry mouth. Companies in the xerostomia drug market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.